U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Fallntolol is a beta-adrenergic receptor antagonist. Falintolol does not produce any noteworthy side effects and is capable of being an effective beta-blocking agent in open-angle glaucoma therapy.

Originator

Curator's Comment: reference retrieved from https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6

Approval Year

PubMed

PubMed

TitleDatePubMed
Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
1984 Oct
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea.
1985 Apr
New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent beta-adrenergic blocking properties.
1985 Jul
Determination of falintolol, a new aliphatic beta-adrenergic antagonist, in whole blood by gas chromatography with electron-capture detection: geometric isomers resolution.
1987 Jan
Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.
1987 Summer
Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
1989 Dec
Substance Class Mixture
Created
by admin
on Sat Dec 16 19:28:46 GMT 2023
Edited
by admin
on Sat Dec 16 19:28:46 GMT 2023
Record UNII
8ZG1XG255D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FALINTOLOL OXALATE
Common Name English
FALINTOLOL OXALATE, (±)-
Common Name English
ETHANONE, 1-CYCLOPROPYL-, O-(3-((1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPYL)OXIME, ETHANEDIOATE (1:1) (SALT)
Systematic Name English
Code System Code Type Description
FDA UNII
8ZG1XG255D
Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023
PRIMARY
CAS
99051-41-9
Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023
ALTERNATIVE
CAS
88134-93-4
Created by admin on Sat Dec 16 19:28:46 GMT 2023 , Edited by admin on Sat Dec 16 19:28:46 GMT 2023
PRIMARY
All of the following components must be present:
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Definition References